BioCryst remains hopeful of FDA approval for its single-dose influenza drug despite mixed results An experimental single-dose influenza drug has demonstrated mixed results in treating adult patients with flu when administered within 48 hours of the onset of symptoms.…
Self-management effective for people with hypertension A new study shows that people who manage their own hypertension appear to have better control of the condition.…
Novel heart failure therapy shows “overwhelming benefit”, trial shows A novel treatment for heart failure could save the lives of 20% more patients than the current gold-standard therapy.…
Erythropoietin provides neuroprotection to preterm infants A trial has found that giving preterm infants human erythropoietin just before and after birth were significantly less likely to have brain abnormalities.…
Brief intervention can help patients with medication-overuse headache A structured brief intervention has the potential to change the views and behaviours of patients with medication-overuse headache.…
Take action to prevent misuse of psychotropic medicines in care homes English Pharmacy Board chairman Dave Branford makes the case for pharmacists to have more input into care home prescribing.…
Domperidone must be supplied on prescription, MHRA rules Domperidone (Motilium), used to treat nausea and vomiting, will be a prescription-only medicine from 4 September 2014.…
Statin use in hospital for haemorrhagic stroke linked to improved survival A retrospective cohort study suggests that statin use among patients with intracerebral haemorrhage improves survival.…
SSRI anti-depressants play a role in the brain’s connectivity, suggests study Further research is needed to establish whether serotonin-induced connectivity changes hold promise to translate into meaningful predictors for antidepressant response…
Atrial fibrillation guideline updates How the latest clinical guidelines change the management of a cardiac arrhythmia affecting 1% of adults in the UK.…